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Mutations in Norrin, the ligand of a receptor complex consisting of FZD4, LRP5 and TSPAN12, cause severe
developmental blood vessel defects in the retina and progressive loss of the vascular system in the inner ear,
which lead to congenital blindness and progressive hearing loss, respectively. We now examined molecular
pathways involved in developmental retinal angiogenesis in a mouse model for Norrie disease. Comparison
of morphometric parameters of the superficial retinal vascular plexus (SRVP), including the number of filo-
podia, vascular density and number of branch points together with inhibition of Notch signaling by using
DAPT, suggest no direct link between Norrin and Notch signaling during formation of the SRVP. We noticed
extensive vessel crossing within the SRVP, which might be a loss of Wnt- and MAP kinase-characteristic fea-
ture. In addition, endomucin was identified as a marker for central filopodia, which were aligned in a thorn-
like fashion at P9 in Norrin knockout (Ndpy/2) mice. We also observed elevated mural cell coverage in the
SRVP of Ndpy/2 mice and explain it by an altered expression of PDGFb and its receptor (PDGFRb). In vivo
cell proliferation assays revealed a reduced proliferation rate of isolectin B4-positive cells in the SRVP
from Ndpy/2 mice at postnatal day 6 and a decreased mitogenic activity of mutant compared with the wild-
type Norrin. Our results suggest that the delayed outgrowth of the SRVP and decreased angiogenic sprouting
in Ndpy/2 mice are direct effects of the reduced proliferation of endothelial cells from the SRVP.
INTRODUCTION
Mutations in the human NDP (Norrie disease pseudoglioma)
gene, encoding Norrin, cause congenital blindness, progres-
sive deafness and mental retardation, a triad of symptoms
characteristic for Norrie disease (ND) (1–5). Alternatively,
mutations in NDP can exclusively lead to ocular symptoms
in X-linked exudative vireoretinopathy (EVR) (6), Coats’
disease and retinopathy of prematurity (7,8). EVR is also
caused by mutations in Frizzled-4 (FZD4, FZD4), low-density
lipoprotein receptor-related protein 5 (LRP5, LRP5) or
tetraspanin-12 (TSPAN12, TSPAN12) (9–11). Recessive
mutations in LRP5 may also cause osteoporosis pseudoglioma
syndrome (OPPG), which manifests with low bone mass in
addition to the ocular phenotype in patients (OMIM:
#259770). It has been shown in vitro that Norrin is a ligand
for the canonical Wnt signaling receptor complex consisting
of FZD4, LRP5 and TSPAN12 (12,13). Furthermore, the out-
growth of the superficial retinal vascular plexus (SRVP) from
Ndpy/2, Fzd42/2, Lrp52/2 and Tspan122/2 is delayed and
incomplete and all of these knockout mice lack the deep and
intermediate retinal vascular plexuses (12–16). We generated
and examined a Norrin knockout mouse model (Ndpy/2) that
resembles the human Norrie disease phenotype with respect
to blindness and hearing loss (4,14,17). Hyaloid vessels do
not completely regress in Ndpy/2, Fzd42/2, Lrp52/2 and
Tspan122/2 knockout mice (12–14,16). Retinal vascular
hemorrhage and exudation from retinal blood vessels in Ndp
knockout mice (Ndpy/2) are characteristic features. We previ-
ously demonstrated that expression of the plasmalemma
vesicle-associated protein (PLVAP), which mediates vascular
fenestration and promotes vascular leakiness, is highly
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upregulated in Ndpy/2 retinas (18). Upregulation of PLVAP/
MECA32 in retinal endothelial cells (ECs) has also been
shown for Lrp52/2 and Tspan122/2 mice (13). Furthermore,
it was shown that upregulation of PLVAP indicates the loss of
canonical Wnt signaling (19). The delayed outgrowth of the
SRVP and the absence of deep sprouting could be caused
either by defects in sprouting angiogenesis or by reduced pro-
liferation of the SRVP. Sprouting angiogenesis is mediated by
endothelial tip cells that guide the growing SRVP from the
optic nerve head towards the retinal periphery along a vascular
endothelial growth factor (VEGF) gradient (20). Stalk cells
following tip cells divide ensuring proliferation and growth.
Thus, an imbalance of tip and stalk cells could lead to both
observed effects. The proper differentiation of tip and stalk
cells is mediated by a balanced expression and interaction of
Notch1 with its ligands Dll4 and Jagged1 (21–23). Dll4 is
expressed in tip cells and induces Notch signaling in adjacent
stalk cells. In contrast, Jagged1 is expressed in stalk cells im-
peding Notch signaling in adjacent tip cells. Disruption of
Notch signaling has been shown to alter morphometric para-
meters, such as the number of peripheral tip cell filopodia, vas-
cular density and the number of vascular branch points. The
outgrowth of the SRVP along the VEGF gradient involves
MAPK signaling. VEGF, provided by astrocytes or retinal
ganglion cells, binds a receptor complex consisting of VEGF
receptor 2 (VEGFR2) and neuropilin 1 (Nrp1) activating
downstream MAPK signaling. Loss of the cytoplasmatic
Nrp1 domain (Nrp1cytoD/D) or nestin-specific knockout of
VEGF (VEGFNES-CRE) in mice causes artery/vein crossing
(A/V crossing) in the SRVP of these mice. VEGFNES-CRE
mice additionally show aberrant deep sprouting (24,25).
Here, we focused on defects during development of the
SRVP in Ndpy/2 mice. We quantified several vascular and
angiogenic parameters and observed extensive vessel crossing
within the SRVP which might be a MAPK-characteristic
feature. We found reduced cell proliferation in the SRVP at
the vascular front at P6 in Ndpy/2 mice which may explain
the delayed outgrowth of the SRVP. We also detected elevated
mural cell (MC) coverage of the SRVP starting at P9, which is
consistent with previously found upregulation of Tie1, Pdgfb
and Pdgfrb. Finally, we report for the first time endomucin-
positive supernumerary central filopodia of the SRVP in
Ndpy/2 retinas culminating at P9, the time point when the
deep retinal vascular plexus (DRVP) normally would develop.
RESULTS
Vascular development in Norrin knockout mice
The wild-type mouse retina is avascular at birth and outgrowth
of the SRVP progresses from the center towards the periphery
from P1 until P8. Because the outgrowth of the SRVP is in-
complete and delayed in Ndpy/2 mice (14), we hypothesized
that there might be an imbalance between tip cell filopodia
and/or adjacent stalk cell proliferation. We quantified the
number of filopodia as well as the vascular density and
number of branch points in the central plexus at the vascular
front at P5 and P7 (Fig. 1) (Supplementary Material,
Table S1). The number of filopodia was significantly increased
but the vascular density (Fig. 1A, C, E, G, I, K) and the
number of branch points (Fig. 1A, C, E, G, J, L) were signifi-
cantly decreased at P5 and P7 in Ndpy/2 mice. Moreover, filo-
podial protrusions in Ndpy/2 mice are straighter and expand
with a narrower angle than filopodia of wild-type littermates
(Fig. 1O) (Supplementary Material, Table S2). In contrast to
the increased number of filopodia, the vascular front in
general appears to be less ramified with a reduced amount of
long tip cell protrusions (Fig. 1B and F).
Comparison of vascular development in different mouse
models
Available morphometric data from three Norrin-Wnt signaling
knockout mice (Fzd42/2, Lrp52/2 and Tspan122/2), three
Notch signaling knockout mice (Dll4+/2, Jag1iDEC,
Nrarp2/2), Ang2LZ/LZ and Pax6 dependent hypoxia inducible
factor 1 a (HIF1aDPax6) knockout mice were compared
(Table 1). The morphometric comparison of Jag1iDEC with
Ndpy/2 mice was of special interest since Jag1 has been
shown to be a canonical Wnt target gene in hair follicle
cells comprising two LEF/TCF-binding sites within its pro-
moter region (26,27). We compared our morphometric data
from Norrin KO mice with published morphometric data
from Jag1iDEC mice and recognized delayed and incomplete
outgrowth of the SRVP, together with a reduced vascular
density and a decreased number of branch points in
Jag1iDEC and Ndpy/2 mice. In contrast to Ndpy/2 mice, the
number of tip cell filopodia was reduced in Jag1iDEC mice.
Dll4+/2 mice have an increased number of filopodia,
increased number of branchpoints and a denser vascular
SRVP. Hence, the Ndpy/2 phenotype of the SRVP displays
as an intermingled picture, with a peripheral Jag1 gain of
function but central Jag1 loss of function features. We asked
the question whether or not Norrin is a negative regulator of
Notch signaling. To answer this question, we examined the
effect of Notch inhibition in Ndpy/2 mice in order to see if
this may rescue the abnormal vascular development. We quan-
tified and compared morphometric parameters in Norrin
knockout and wild-type mice after inhibition of Notch signal-
ing by injection of the g-secretase inhibitor DAPT (Fig. 2).
Administration of DAPT increased vascular density in wild-
type and Ndpy/2 mice (Fig. 2A–E), while the number of filo-
podia only increased in wild-type but not in Ndpy/2 retinas
(Fig. 2F–J) (Supplementary Material, Table S3).
Retinal EC proliferation in Norrin-deficient mice
To test the hypothesis if Norrin acts as a mitogen for cells in
the SRVP, which would explain the reduced vascular density
as well as the delayed and incomplete radial vascular out-
growth in Ndpy/2 mice, we quantified central EC proliferation
after systemic bromodeoxyuridine (BrdU) injection and found
significantly reduced proliferation rates of isolectin B4
(IB4)-positive ECs from the SRVP in Ndpy/2 mice at P6
(WT: ME+SD 101.71+ 16.54; KO: ME+SD 52.17+
9.62; P-value: 1.8E25) (Fig. 3A and C). The only exceptions
from this observation are local hotspots of proliferation within
bulky unorganized regions at the vascular front (Fig. 3D).
Additionally, we monitored the effect of Norrin on cell
cycle progression in cell culture experiments by using an
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E2F transcription factor-mediated reporter assay (cell prolifer-
ation controlling transcription factor-dependent luciferase re-
porter construct, reviewed in 28). For this, we transiently
transfected pE2F luciferase reporter constructs into
HEK293T cells which ectopically express the same amount
of either human wild-type or a pathogenic variant of Norrin
containing the p.C95R mutation (Supplementary Material,
Fig. S1), which has been associated with the classic picture
of Norrie disease (29). HEK293T cells do not endogenously
express Norrin, but were positive in RT–PCR for transcripts
from FZD4, LRP5 and TSPAN12 (Supplementary Material,
Fig. S1). Similarly to our BrdU data in Ndpy/2 mice, we
found almost 6-fold increased cell cycle progression in cells
that stably express human wild-type Norrin compared with
cells that express the mutant Norrin isoform (Fig. 3F, Supple-
mentary Material, Table S4).
Vascular remodeling in Norrin-deficient mice
Despite the reduced vascular outgrowth of the SRVP, we
occasionally noticed bulky vascular areas at the front of
Ndpy/2 mice, comprising three-dimensional accumulations
of ECs (Fig. 4D). To monitor vascular remodeling across the
plexus, retinal whole-mounts were double stained for IB4
and collagen IV (ColIV). ColIV-positive tubes lacking IB4
staining represent empty basement membrane sleeves at posi-
tions where blood vessels have regressed (30,31). We noticed
that vascular remodeling was elevated in Ndpy/2 mice at per-
ipheral bulky vascular areas of the SRVP, but not in central
areas (Fig. 4C, white dots). Furthermore, we noticed
vessel-crossing in Ndpy/2 retinas. Vessels that morphological-
ly resemble veins [venous character (VC)] cross and grow
below vessels that resemble arteries [arterial character (AC)]
between P7 and P21 (A/V crossing) (Fig. 5, Supplementary
Material, Fig. S3). ACs in Norrin knockout mice also intercon-
nect less to the central plexus compared with the wild-type and
instead grow further into the periphery (Fig. 6D). At P21, dis-
organized twisted and tangled blood vessels form above the
superficial plexus resembling fibrosis (Supplementary Mater-
ial, Fig. S3t and w). We hypothesized that A/V crossing
could be caused by altered astrocyte–EC interaction and
therefore co-stained astrocytes against PDGFRa and blood
Figure 1. Morphometric parameters in Norrin knockout versus wild-type mice. Ndpy/2 mice show decreased vascular density, a decreased number of branch
points but supernumerary filopodia, which are aligned in a more narrow angle compared with wild-type mice at P5 and P7. (A, E, C, G) Representative central
retinal whole-mounts from wild-type (WT) and Ndpy/2 (KO) retinas stained with IB4. (B, D, F, H) Representative peripheral retinal whole-mounts from WT and
Ndpy/2 retinas stained with IB4. Emerging filopodia are visible. Quantification of vascular density (I and K), number of branch points (J and L), number of
filopodia (M and N) and angle of filopodia (O). Average and confidence intervals are shown. P-values below a ¼ 0.05 were considered statistically significant.
Scale bars ¼ 100 mm.
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Table 1. Morphometric data among mutant mice with comparable retinal vascular phenotype
Ndpy/2 Fzd42/2 Lrp52/2 Tspan122/2 Dll4+/2 Jag1iDEC Nrarp2/2 Ang2LZ/LZ HIF1aDPAX6
Pathway affected Canonical
Wnt-
signaling
Canonical
Wnt-
signaling
Canonical Wnt-
signaling
Canonical
Wnt-
signaling
Notch signaling Notch signaling;
tamoxifen-induced
EC-specific deletion
Notch, b-catenin/
Lef1-dependent Wnt
signaling
Tie2 signaling;
LZ ¼ lacZ
Hypoxia
Vascular
outgrowth of
SRVP
Delayed and
incomplete
Delayed and
incomplete
Delayed and
incomplete
Delayed and
incomplete
Delayed Delayed (244%) Delayed but complete Periphery
remains
avascular
Not delayed
nor reduced
Vascular density
of SRVP
Reduced
(234%, P7)
Not available Not available Reduced Increased
(+58%a)
Reduced (232%, P6) Reduced at P5 but not
different in adult
Not available Not available
Number of branch
points of
SRVP
Reduced
(247%, P7)
Not available Not available Not available Increased
(+96%a)
Reduced (265%, P6) Reduced at P5 but not
different in adult
Not available Not available
Number of
filopodia of
SRVP
Increased
(+39%, P7)
Not available Not available Not available Increased
(sprouts
increased
+63%a)
Reduced (227%, P6) Not different at P5 Not available Not available
A/V crossing in
SRVP till P7
Present Present Present Present Absent Absent Present Not deducible
due to
picture
quality
Absent
DRVP Absent Absent Absent Absent Present Present Present Absent Present
Intermediate
retinal vascular
plexi
Absent Absent Absent Absent Present Present Present Absent Absent
References Luhmann et al.
(14), this
work
Xu et al. (12) Xia et al. (16,41)
and Chen
et al. (42)
Junge et al.
(13)
Lobov et al.
(21)
Benedito et al. (22) Phng et al. (43) Gale et al. (44) Caprara et al.
(45)
a% estimated from graph.
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vessels with IB4 (Supplementary Material, Fig. S2). We did
not observe an altered astrocytic network in Ndpy/2 retinas
compared with wild-type and alignment between astrocytes
and ECs was normal.
Mice lacking the Nrp1 cytoplasmatic domain or
VEGFNES-CRE mice also show A/V crossing in the SRVP
(24,25). This suggests that the loss of MAPK signaling
might cause this phenotype. Therefore, we made use of our
stably wild-type or p.C95R Norrin expressing HEK293T cell
lines (Supplementary Material, Fig. S1) to monitor MAPK ac-
tivity. We found a 1.9-fold increase in MAPK signaling in
cells that express wild-type Norrin compared with those that
expressed the mutant, disease-associated variant (Fig. 5I, Sup-
plementary Material, Table S5).
Because of the above-described, strong SRVP phenotype in
Ndpy/2 mice, it was crucial to examine whether the VCs and
ACs exhibit characteristic molecular features of the respective
vessel types. Retinal flatmounts were stained either for endo-
mucin or for smooth muscle actin (SMA) at P7, P9, P12 and
P21. In both, wild-type and Ndpy/2 mice, endomucin stained
veins and venous portions while staining of arteries and arter-
ioles was less intense (Fig. 6, Supplementary Material, Fig. S4)
(32,33). Interestingly, the endomucin staining revealed super-
numerary thorn-like assembled central filopodia around veins
and capillaries of Ndpy/2 retinas (Fig. 6D and E). In contrast,
capillary sprouts were much less abundant and, if present,
much shorter in wild-type mice. Staining for the arterial and
MC marker a-SMA in wild-type mice specifically labeled
arteries at P7, P9 and P12 as well as arteries and large veins
at P21. In Ndpy/2 retinas, arteries, veins and capillaries were
covered with SMA-positive cells at P9, P12 and P21 (Fig. 7,
Supplementary Material, Fig. S5). Thus, MC recruitment to
the SRVP is abnormally increased in Ndpy/2 retinas.
DISCUSSION
Deficiency of Norrin is known to cause Norrie disease, a
severe X-linked recessive human disease characterized by
congenital blindness, progressive hearing loss and, in some
patients, mental retardation. We made use of a mouse model
which mimics the human disease in eye and ear and applied
morphometric analyses, Notch-inhibition by DAPT adminis-
tration, as well as cell proliferation assays to characterize the
angiogenic processes in the retina. We provide evidence that
Norrin is a mitogenic stimulus for cells in the SRVP. Consist-
ently, wild-type Norrin promotes E2F transcription factor-
mediated cell cycle progression in a cell culture assay.
Further, we identified endomucin as a marker for central filo-
podia, which were aligned in a thorn-like fashion at P9 in
Ndpy/2 mice. Finally, we found aberrant vascular SMA-
positive MC coverage of veins and capillaries in the SRVP
Figure 2. Effects of Notch signaling inhibition in wild-type and Norrin knockout mice. Pharmacological administration of DAPT increases vascular density at
the vascular front in wild-type and Ndpy/2 mice. The number of filopodia only increases in wild-type but not in Ndpy/2 mice upon DAPT treatment. (A–D)
Representative retinal whole-mounts stained with IB4 48 h after DAPT injection in P7 wild-type (WT) and Ndpy/2 (KO) animals. (E) Statistical analysis
shows that peripheral vascular density increases in both genotypes upon DAPT treatment. (F–I) Representative retinal whole-mounts of IB4 staining 48 h
after DAPT treatment of P7 wild-type (WT) and Ndpy/2 (KO) animals. Filopodia at the vascular front are visible. (J) Statistical analysis shows that number
of filopodia increases only after DAPT treatment in the WT but not in Ndpy/2 mice. P-values below a ¼ 0.05 were considered statistically significant. Scale
bars ¼ 100 mm.
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in Ndpy/2 mice which indicates abnormally increased MC re-
cruitment of the SRVP from Norrin KO mice.
Norrin and Notch signaling are not directly linked
We examined features of the SRVP in Ndpy/2 mice by quan-
tifying and comparing morphometric parameters (Figs 1 and 2,
Supplementary Material, Tables S1–S3) with published data
from different mouse models with retinal vascular phenotypes
(Table 1). We did not quantify later stages than P7 since the
outgrowth of the superficial plexus in wild-type mice ends
soon after this stage of development.
We noticed that the outgrowth of the SRVP is delayed in all
mouse models (Table 1), but incomplete vascular outgrowth
was only observed in mutants with disrupted canonical Wnt
signaling (Ndpy/2, Fzd42/2 and Lrp52/2). Both the deep
and intermediate retinal vascular plexuses (DRVP, IRVP)
are absent in mice with deficient Wnt signaling components
(Ndpy/2, Fzd42/2, Lrp52/2 and Tspan122/2) and in
Ang2LZ/LZ mice, but not in Notch signaling deficient mice
(Dll4+/2 or Jag1iDEC). The intermediate plexus is absent in
HIF1aDPax6 mice, while the deep plexus is present
(Table 1). We hypothesized that the canonical Wnt target
gene Jag1 might link Norrin-Wnt and Notch signaling
during development of the SRVP, since knocking out Ndp or
Jag1 leads to aberrant SRVP development. However, we
found significant differences in morphometric parameters
between Ndpy/2 and Jag1iDEC retinas, which are in conflict
with this hypothesis. The number of filopodia was increased
in Ndpy/2 and reduced Jag1iDEC mice. Jag1iDEC retinas also
do not display defects in deep vascular development (22)
which is a characteristic feature in Ndpy/2 retinas. All these
phenotypic differences suggest that there is no direct link
between Norrin-Wnt and Notch signaling via Jag1.
Inhibiting Notch signaling through systemic DAPT admin-
istration led to an increased vascular density in Ndpy/2 mice,
but it did not reduce the supernumerary filopodia. Further-
more, vascular density increased similarly in wild-type and
Ndpy/2 retinas after DAPT treatment, excluding a synergistic
effect (Fig. 2E). Accordingly, interaction effects were rejected
by univariate analysis of variance (data not shown). Although
the peripheral vascular network at the front is denser in DAPT-
treated Ndpy/2 mice (Fig. 2D), it still seems disorganized,
three-dimensional and not planar. This implies that Notch in-
hibition can induce a peripheral hyper angiogenic response in
Ndpy/2 mice but not re-establish normal vascular develop-
ment. The diameter of the peripheral blood vessels increased,
which might be due to involvement of Dll4-Notch signaling in
A/V differentiation, leading to a more pronounced venous
phenotype after DAPT injection and to an increase in vessel
diameter (Fig. 2A–D). The number of filopodia significantly
Figure 3. Decreased proliferation rate of ECs in Norrin knockout mice and
reduced cell cycle progression due to a mutation (p.C95R) in human Norrin.
Overall proliferation is reduced in Ndpy/2 mice at P6. Representative retinal
whole-mounts of wild-type (WT) (A and B) and Ndpy/2 mice (KO) (C and
D) were stained for blood vessels with IB4 (red) and for proliferating cells
after BrdU incorporation (green). (D) Local hotspots of proliferation within
thickened areas of the vascular front are occasionally seen in Ndpy/2 mice
and were excluded from quantification of proliferation. (E) Quantification of
proliferating vascular ECs after BrdU-incorporation revealed a reduced
proliferation rate (238%) in Ndpy/2 mice. (F) Expression of wild-type
Norrin (WT) leads to 5.6-fold increase in the proliferation rate in HEK293T
cells compared with cells expressing a mutant (p.C95R) human Norrin.
Average and confidence intervals are shown. P-values below a ¼ 0.05 were
considered statistically significant. Scale bars ¼ 100 mm.
Figure 4. Massive vessel regression at the bulky vascular front in Ndpy/2 mice
at P7. IB4 (green) and ColIV (red) co-stained retinal whole-mounts from wild-
type (WT) (A and B) and Ndpy/2 mice (KO) (C and D). ColIV+,
IB4-stainings represent empty membrane sleeves, where blood vessels have
regressed (white dots). Regression was increased at the bulky vascular front
in Ndpy/2 retinas (D). Scale bars ¼ 100 mm.
2624 Human Molecular Genetics, 2012, Vol. 21, No. 12
increased in wild-type mice, but was unaltered in Ndpy/2
retinas upon DAPT administration (Fig. 2G, I, J).
Vascular remodeling in Norrin-deficient mice
We found enhanced vascular proliferation (Fig. 3) and also
enhanced vascular regression/remodeling (Fig. 4) at the
vascular bulky front in Ndpy/2 mice after BrdU injection
and by co-staining of ColIV and IB4. We interpret the
vessel regression of Ndpy/2 retinas as secondary effect
which ensures a planar vascular plexus at positions where
bulky vascular fronts were present before moving towards
the periphery. Disorganized vascular fronts are also present
in Fzd42/2, Lrp52/2 and Tspan122/2 retinas (12,13,34).
Figure 5. Blood vessel crossing in Norrin knockout mice. Arteries and veins often cross each other in Ndpy/2 retinas. Retinal whole-mounts of wild-type (WT)
(A–C) and Ndpy/2 mice (KO) (D–H) were stained with IB4 to label blood vessels (green A–F, or grey G + H). We noticed abundant A/V crossings at the
center (E, arrowheads) and periphery (F, arrowheads) of the SRVP from Ndpy/2 retinas. Note, that (E) represents the box indicated in (D). (G) and (H) are
confocal images from the blood vessels marked in (E), focused on the upper artery (G), and on the lower vein (H). The distance between both vessels is
3.58 mm. (I) Ectopic expression of wild-type Norrin (WT) leads to 1.9-fold increase in MAPK signaling in HEK293T cells compared with cells expressing
a mutant (p.C95R), disease-associated human Norrin. a, artery; ac, arterial character; v, vein; vc, venous character. Scale bars ¼ 100 mm.
Figure 6. Large central filopodia in Ndpy/2 mice at P9. Retinal whole-mounts from wild-type (WT) (A–C) and Ndpy/2 mice (KO) (D–F) were co-stained with
IB4 (green) to label blood vessels and with endomucin (red) which preferentially stains veins, venous vessels and central filopodia. (B) represents box in (A) and
(E) represents box in (D). Endomucin staining revealed that vessels with a venous character (vc) but not with an arterial character (ac) are laced with super-
numerary central filopodia. a, artery; v, vein. Scale bars ¼ 100 mm.
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Further, we observed extensive crossing of arteries and veins
(A/V) in Ndpy/2 retinas and we excluded an altered astrocytic
scaffold to be the reason for these observations (Supplemen-
tary Material, Fig. S2).
Loss of Norrin signaling might alter MAPK signaling
A/V crossing is a feature of all Norrin-Wnt signaling deficient
mice and also (12,13,16,24,25) the lack of the cytoplasmatic
Figure 7. Retinal veins and capillaries are abundantly covered by mural cells (MCs) in Ndpy/2 mice at P12. Retinal whole-mounts were co-stained with IB4 to
label blood vessels (green) and against SMA to label arteries covered by MCs (red). Only arteries were covered by MCs in wild-type (WT) retinas. In contrast,
arteries, veins and capillaries were covered by MCs in Ndpy/2 retinas (KO). a, artery; ac, arterial character; v, vein; vc, venous character. Scale bars ¼ 100 mm.
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domain of Nrp1 (Nrp1cytoD/D) or dosage-dependent reduction
in neuronal VEGF-A paracrine signaling (VEGF-ANES-CRE)
lead to A/V crossing (24,25). The receptor pair consisting of
VEGFR2 and Nrp1 triggers VEGF-mediated downstream
MAPK signaling. Thus, the existence of A/V crossing in
Ndpy/2 retinas and in retinas from VEGF-ANES-CRE and
Nrp1cytoD/D mice suggests that both pathways influence each
other. Supporting this, Norrin-stimulated cells have elevated
MAPK signaling activity compared with cells stimulated
with mutant Norrin (Fig. 5I). Similarly, we previously reported
MAPK signaling to be the major pathway influenced by
Norrin signaling according to transcriptome analyses using
microarray data from Ndpy/2 retinas (18). Therefore, it will
be intriguing to investigate the putative link between
Norrin-Wnt and VEGF/Nrp1/MAPK signaling.
Norrin stimulates mitogenic activity in retinal ECs
Since the loss of Norrin leads to delayed and incomplete out-
growth of the SRVP, we analyzed the mitogenic activity of
Norrin in mouse retinas and in cell culture using systemic
BrdU injection and reporter assays, respectively. The
reduced proliferation of IB4-positive ECs from the SRVP in
Ndpy/2 retinas, as revealed after BrdU injection, indicates
that Norrin might act as a mitogenic stimulus (Fig. 3). Add-
itionally, we monitored cell cycle progression by using the
pE2F luciferase reporter construct. As expected, HEK293T
cells, which endogenously express FZD4, LRP5 and
TSPAN12 but not Norrin, and ectopically express human
wild-type Norrin had an increased cell cycle progression com-
pared with ectopically p.C95R mutant Norrin expressing cells
(Fig. 3F). Consistently, Ohlmann et al. (35) observed, by using
a BrdU ELISA, that Norrin efficiently stimulates proliferation
of human retinal microvascular ECs in vitro in a
Wnt-dependent manner. Our findings together with the BrdU
ELISA suggest that Norrin might act as a mitogenic stimulus
on microvascular/capillary ECs of the SRVP (Fig. 3C). This
also can explain the delayed outgrowth of the SRVP. A key
to understand the complexity of the retinal vascular phenotype
in Ndpy/2 mice could be the differentiated view of events at
the angiogenic front and within the central plexus. Transient
peripheral phenomena like local hotspots of proliferation and
remodeling, thickening of the vasculature and supernumerary
filopodia could be interpreted as inability of vascular sprouts
to escape the existing plexus. Hence, filopodia-projecting tip
cells could be overrun by stalk cells, cluster and form the
observed bulky areas. The supposed explanation for the
Ndpy/2 superficial plexus phenotype is also supported by in
silico models of vascular network formation. Travasso et al.
(36) recently found, utilizing a mathematical model of sprout-
ing angiogenesis, that low tip cell motility leads to a sparsely
ramified plexus and increased stalk cell proliferation. Due to
the lack of long tip cell protrusions projecting into the avascu-
lar space ahead of the vascular front, also characteristic for
Ndpy/2 mice, stalk cells spend more angiogenic factors
which decrease its concentrations and inhibits branching.
The same study highlights that low overall EC proliferation
also leads to reduced vessel ramification, corroborating our
observations.
Veins and capillaries of Ndpy/2 retinas possess
supernumerary central filopodia
To investigate the properties of ACs and VCs, we stained
retinal whole-mounts against endomucin and SMA.
The surface of veins and capillaries in Ndpy/2 retinas was
laced with endomucin-positive filopodia instead of being
smooth and covered with none or very few filopodia as in
control mice. The abundance of central filopodia peaks
around P9, exactly when deep vascular sprouting in wild-type
mice occurs. Interestingly, deep sprouting exclusively origi-
nates from venous vessels and capillaries but not from arteries.
Therefore, it seems that veins and capillaries of the SRVP
from Ndpy/2 retinas are able to create misaligned central filo-
podia. However, these filopodia might not be functional, since
Ndpy/2 mice lack deep sprouting. It is also unclear which mo-
lecular mechanisms lead to those central supernumerary filo-
podia since published data focuses exclusively on the
regulation of tip cell filopodia.
Veins and capillaries of Ndpy/2 retinas are excessively
covered by MCs
Staining of retinal blood vessels for SMA revealed extensive
MC coverage of veins and capillaries from P9 onwards. This
coverage persists at least till P21. We previously reported
upregulation of PDGFb and PDGFRb within the same time-
frame (14). Interaction of all these genes regulates MC recruit-
ment. Here, overexpression of PDGFb and its receptor
(PDGFRb) could stimulate MC recruitment and the missing
upregulation of Ang1 on MCs might prevent restriction of
MC recruitment. Considering this as the likely mechanism
of the excessive MC recruitment, we believe that this might
be a response to vessel leakiness caused by upregulation of
VEGF-A and PLVAP (14,18) due to hypoxia. Currently, it is
unclear if this extensive MC recruitment goes along with a
gain of AC in the affected veins and venules. If so, the gain
in arterial or loss of VC could explain the disability to form
the DRVP out of the SRVP from Ndpy/2 retinas, since deep
sprouts emerge exclusively from venous vessels and capillar-
ies of the SRVP (37). The fact that we still can morphologic-
ally distinguish ACs and VCs and that we detected
supernumerary endomucin-positive central filopodia on
veins, venules and capillaries, but not on arteries, argues
against a complete loss of the VC. However, the formation
of uncoordinated central endomucin-positive filopodia at P9
and the excessive MC recruitment of venous vessels may indi-
cate at least a partial loss of venous identity of the respective
ECs with the consequence that central tip cells might develop,
but being unable to induce proper deep sprouting.
The morphometric analysis together with results from the
DAPT injections does not suggest a direct link between
Norrin-Wnt and Notch signaling via Jag1. Our results
suggest that Norrin is a mitogenic stimulus for IB4-positive
ECs of the SRVP which explains its delayed outgrowth in
Ndpy/2 mice. The A/V crossing occurs unlikely due to a dis-
turbed astrocyte–EC interaction and it is unclear if the
altered basal membrane of the SRVP contributes to this
effect. We found that Norrin is able to stimulate MAPK sig-
naling and also previously reported that MAPK signaling
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might be the primarily altered pathway in Norrin KO retinas.
All this together with the A/V crossing phenotype suggests
that MAPK signaling might be significantly altered in Norrin
KO retinas. We also found excessive MC coverage of veins,
venules and capillaries in Ndpy/2 retinas which might indicate
a partial loss of venous identity but also contribute to the ap-
pearance of the altered basal lamina and possibly to the ap-
pearance of the thorn-like supernumerary central filopodia.
Postnatal stages after P7 in mice mimic developmental
stages from patients when hypoxia increases and leads to
pathologic alterations of various retinal angiogenic maturation
processes. These data are crucial for the investigation of
related diseases, like familial exudative vitreoretinopathy or
Coats’ disease, with a less severe phenotype than Norrie
disease, which have a realistic chance for the development
of treatment regimens.
MATERIALS AND METHODS
Animals
Generation of the Ndpy/2 mouse line has been described else-
where (4). The research was performed in accordance with the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research and was approved by the Veterinary Office
of the State of Zurich (Switzerland).
Immunohistochemical staining
Retinas for whole-mount immunohistochemistry were fixed in
4% paraformaldehyde for 2 h or overnight at 48C. After fix-
ation, retinas were blocked using 1–10% normal goat or
rabbit serum (VectorLabs) in PBST and subsequently incu-
bated overnight with biotinylated IB4 (1:200; VectorLabs).
The following primary antibodies were diluted in 1–5%
serum in PBST and incubated over night: aSMA-CY3
(1:500; Sigma), ColIV (AbD serotec, 1:200), PDGFRa
(R&D Systems, 1:500) and Endomucin (R&D Systems,
1:100). For secondary detection, Alexa Fluor streptavidin con-
jugates (Molecular Probes, 1:100) or anti-goat/rabbit Alexa
Fluor-coupled secondary antibodies (Invitrogen, 1:500) were
used. Retinas were washed five times with PBS, flat
mounted and analyzed under bright-light illumination with a
microscope (Axioplan 2, AxioCam HRc; Carl Zeiss) equipped
with ApoTome (Carl Zeiss) or by confocal imaging using the
CLSM Leica SP2 inverse microscope (Leica). The protocol
from Pitulescu et al. (46) was used to stain for proliferating
ECs (BrdU staining).
Image processing
Image J 1.44p (NIH) and Photoshop CS5 (Adobe) software
were used for image processing. Overall image brightness
was adjusted in a linear fashion on whole images if it was ne-
cessary to improve picture quality for prints. These adjust-
ments did not influence interpretation and are in concert
with suggestions for image processing in reference (38).
Results shown were obtained by performing at least two dif-
ferent independent experiments including at least four
mutant or control animals per stage.
Morphometric analysis of retinal flatmounts
Each morphometric parameter was determined by averaging
over four non-overlapping images per retina (one retina used
per animal) with a minimum of four animals per group. Vas-
cular density was determined by measuring the endothelial
coverage per 300 × 300 mm field at the vascular front. The
number of branch points was determined by counting vessel
branch points within 300 × 300 mm fields. The number of filo-
podia at the vascular front within 68 × 51 mm fields was
counted and normalized to 100 mm length of vasculature.
BrdU-positive endothelial nuclei were counted in 424 ×
317 mm fields at the vascular front and normalized to endothe-
lial coverage within the same field (21).
In vivo Notch inhibition
Notch signaling was inhibited by subcutaneous injection
of 0.3 mg/g body weight N-[N-(3,5-Difluorophenacetyl-
L-alanyl)]-S-phenylglycine t-butylester (DAPT, Merck)
dissolved in 10% ethanol and 90% peanut oil. DAPT solution
was injected twice at P5 and P6. Retinas were collected at P7.
Control litters were injected with vehicle only. Seven litters
were DAPT injected. Quantification of vascular density and
number of filopodia in DAPT-treated versus untreated KO
and WT mice were performed as described above (23).
Quantification of Norrin-dependent proliferation and
MAPK signaling in vitro
Stably wild-type or mutant p.C95R Norrin expressing
HEK293T cells were used in these assays. Equal expression
levels of wild-type and mutant Norrin were determined by
western blot analysis (data not shown). To examine the prolif-
eration rate or MAPK signaling activity, 8 × 104 cells/well of
a 24-well plate were seeded and incubated at 378C/5% CO2
overnight. Cells were transiently co-transfected with pE2F or
pSRF firefly luciferase reporter and pRenilla constructs
(SABiosciences) using the calcium precipitation method
(39,40). Luciferase activity was measured using DualGlo-
LuciferaseReporterAssaySystem (Promega). Firefly luciferase
activity was normalized to co-transfected Renilla luciferase.
Statistical analysis
Statistical analysis was performed in SPSS 18.0 (IBM) using
two-tailed unpaired Student’s t-test.
Quantitative data from DAPT-injection experiments were
processed with univariate analysis of variance with two inde-
pendent variables. Avoiding bias due to unequal sample sizes,
the estimated marginal means were calculated instead of arith-
metically means. P-values below a ¼ 0.05 were considered
significant.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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